Reneo Pharmaceuticals Inc (RPHM)
1.73
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 15:35
Reneo Pharmaceuticals Total Assets (Quarterly): 107.44M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 107.44M |
| September 30, 2023 | 130.39M |
| June 30, 2023 | 148.04M |
| March 31, 2023 | 98.87M |
| December 31, 2022 | 108.18M |
| September 30, 2022 | 122.50M |
| June 30, 2022 | 133.61M |
| Date | Value |
|---|---|
| March 31, 2022 | 144.41M |
| December 31, 2021 | 154.02M |
| September 30, 2021 | 162.94M |
| June 30, 2021 | 171.30M |
| March 31, 2021 | 95.32M |
| December 31, 2020 | 55.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
55.22M
Minimum
Dec 2020
171.30M
Maximum
Jun 2021
125.56M
Average
130.39M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 646.62M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.83M |
| Shareholders Equity (Quarterly) | 88.61M |